Back to Search
Start Over
Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.
- Source :
-
Diabetes care [Diabetes Care] 2020 Sep; Vol. 43 (9), pp. e108-e110. Date of Electronic Publication: 2020 Jul 09. - Publication Year :
- 2020
- Subjects :
- Adult
Aged
Cardiovascular Diseases diagnosis
Cardiovascular Diseases prevention & control
Diabetes Mellitus, Type 2 diagnosis
Diabetes Mellitus, Type 2 epidemiology
Diabetic Angiopathies diagnosis
Drug Therapy, Combination
Female
Hospitalization statistics & numerical data
Humans
Hypoglycemic Agents pharmacology
Hypoglycemic Agents therapeutic use
Liraglutide administration & dosage
Male
Middle Aged
Prevalence
Prognosis
Randomized Controlled Trials as Topic statistics & numerical data
Retrospective Studies
Treatment Outcome
Cardiovascular Diseases epidemiology
Cardiovascular System drug effects
Diabetes Mellitus, Type 2 drug therapy
Diabetic Angiopathies epidemiology
Liraglutide pharmacology
Metformin administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1935-5548
- Volume :
- 43
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Diabetes care
- Publication Type :
- Report
- Accession number :
- 32647053
- Full Text :
- https://doi.org/10.2337/dc20-0437